|
Originally published In Press as doi:10.1074/jbc.M010488200 on May 21, 2001
J. Biol. Chem., Vol. 276, Issue 32, 30326-30334, August 10, 2001
A Novel Heme Protein, the Cu,Zn-Superoxide Dismutase
from Haemophilus ducreyi*
Francesca
Pacello ,
Paul R.
Langford§,
J. Simon
Kroll§,
Chiara
Indiani¶,
Giulietta
Smulevich¶,
Alessandro
Desideri ,
Giuseppe
Rotilio , and
Andrea
Battistoni **
From the Dipartimento di Biologia and
INFM, Università di Roma Tor Vergata, Via della
Ricerca Scientifica, 00133 Roma, Italy, the § Molecular
Infectious Diseases Group, Department of Paediatrics, Imperial College
School of Medicine, St. Mary's Hospital, Norfolk Place,
London W2 1PG, United Kingdom, and the ¶ Dipartimento di
Chimica, Universita' di Firenze, Via G. Capponi 9, 50121 Firenze, Italy
Received for publication, November 20, 2000, and in revised form, April 19, 2001
 |
ABSTRACT |
Haemophilus ducreyi, the causative
agent of the genital ulcerative disease known as chancroid, is unable
to synthesize heme, which it acquires from humans, its only known host.
Here we provide evidence that the periplasmic Cu,Zn-superoxide
dismutase from this organism is a heme-binding protein, unlike all the
other known Cu,Zn-superoxide dismutases from bacterial and eukaryotic species. When the H. ducreyi enzyme was expressed in
Escherichia coli cells grown in standard LB medium, it
contained only limited amounts of heme covalently bound to the
polypeptide but was able efficiently to bind exogenously added hemin.
Resonance Raman and electronic spectra at neutral pH indicate that
H. ducreyi Cu,Zn-superoxide dismutase contains a
6-coordinated low spin heme, with two histidines as the most likely
axial ligands. By site-directed mutagenesis and analysis of a
structural model of the enzyme, we identified as a putative axial
ligand a histidine residue (His-64) that is present only in the
H. ducreyi enzyme and that was located at the bottom of the
dimer interface. The introduction of a histidine residue in the
corresponding position of the Cu,Zn-superoxide dismutase from
Haemophilus parainfluenzae was not sufficient to confer the
ability to bind heme, indicating that other residues neighboring His-64
are involved in the formation of the heme-binding pocket. Our results
suggest that periplasmic Cu,Zn-superoxide dismutase plays a role in
heme metabolism of H. ducreyi and provide further evidence
for the structural flexibility of bacterial enzymes of this class.
 |
INTRODUCTION |
Bacteria have evolved different strategies to acquire iron, an
essential element for all organisms, and to protect themselves from its
potential toxic effects (1). The problem of iron availability is
particularly important for those microorganisms that colonize animal
hosts, where most of the extracellular iron is tightly bound to plasma
proteins. Strategies to overcome limitation in iron availability
include the production of siderophores and the use of host compounds
containing iron, such as heme, hemoglobin, transferrin, and
lactoferrin (2).
Haemophilus ducreyi, the etiological agent of the sexually
transmitted human genital ulcerative disease known as chancroid, is
unable to synthesize heme, and therefore must obtain this from its
host. Although chancroid is relatively uncommon in the United States
and Western Europe, it is one of the most prevalent sexually transmitted diseases worldwide and is an important cause of morbidity in the developing world. Recent studies have provided evidence that
chancroid is a significant cofactor for the heterosexual spread of the
human immunodeficiency virus, type 1, increasing the risk of acquiring
human immunodeficiency virus infection 2-5-fold (3, 4). This
observation, together with the emergence of antibiotic-resistant
strains in areas where this disease is widespread, has stimulated
increasing research effort aimed at understanding the pathogenesis of
chancroid and characterizing H. ducreyi virulence factors,
including proteins involved in heme uptake, that might be exploited in
developing new strategies to prevent infection.
Free heme, hemoglobin, or catalase can supply the iron and heme
requirement for H. ducreyi in vitro (5, 6). Little is known
about mechanisms of heme uptake in this bacterium, but a few proteins
involved in heme and hemoglobin utilization have been cloned (7, 8).
Recently, it has been observed that an H. ducreyi hemoglobin
receptor mutant is unable to initiate disease, thus suggesting that the
main source of heme in vivo is hemoglobin (9).
A few other putative virulence determinants of H. ducreyi
have been described, including a hemolytic cytotoxin (10), a soluble cytolethal distending toxin (11), a lipooligosaccharide molecule (12),
the unique pili which may favor cell attachment (13), and
Cu,Zn-superoxide dismutase
(Cu,Zn-SOD)1 (14, 15). This
latter virulence factor is shared by several Gram-negative bacteria,
including some important pathogens (16). In view of its periplasmic
location, it has been proposed that bacterial Cu,Zn-SOD, by its ability
to scavenge the superoxide radical at diffusion-controlled rates, could
provide protection from the oxygen free radicals produced in the
respiratory burst of the phagocytic host defense. This hypothesis is
supported by recent studies that have shown that periplasmic Cu,Zn-SOD
could confer protection from oxidative damage caused by exposure to phagocytic cells (17, 18) and that sodC null mutants of
Brucella abortus, Salmonella typhimurium, and
Neisseria meningitidis are attenuated in animal infection
studies (19-23). In the case of H. ducreyi, it has been
shown that Cu,Zn-SOD confers some protection against superoxide
generated in vitro (15) and that a Cu,Zn-SOD-deficient strain is more sensitive than wild type to killing by neutrophils in a
swine model of chancroid (24).
In the context of our studies on periplasmic Cu,Zn-SODs from pathogenic
bacteria (14, 16, 18, 20, 23, 25-27), we have undertaken a
characterization of the enzyme from H. ducreyi. Here we
report that the recombinant enzyme expressed in Escherichia coli is able to bind heme with efficiency and specificity, and we
suggest that a single heme moiety is bound at the enzyme-dimer interface. Our data suggest that, beside its ability to protect the
bacterium from oxidative damage, Cu,Zn-SOD might also play a role in
heme transport or detoxification in H. ducreyi.
 |
EXPERIMENTAL PROCEDURES |
Bacterial Strains, Plasmids, and Growth Media--
E.
coli K12 strains and plasmids used in this work are listed in
Table I. All the strains were grown in
standard Luria-Bertani (LB) medium, with the exception of the H500
strain that required the addition of 0.2% glucose. Heme binding by
Cu,Zn-SOD expressed in 71/18 cells was also tested in M9 minimal medium
(40).
Plasmid pPHSOD directing the expression of wild type human Cu,Zn-SOD in
the bacterial periplasmic space was obtained as follows: the sequence
coding for the enzyme was amplified by PCR using the oligonucleotides
5'- ATCCATGGCCGCGACGAAGGCCGTCTGC and 5'-CAGAATTCTTATTGGGCGATCCCAATTAC and plasmid pKH (39) as a template. Amplified DNA was digested with
NcoI and EcoRI and inserted in the corresponding
sites of plasmid pHEN-1 (34).
Site-directed Mutagenesis--
Site-specific mutants were
prepared according to a procedure described previously (41), involving
a two-step PCR. In the first step of H. ducreyi Cu,Zn-SOD
mutant construction, we used the oligonucleotide
5'-CTAAGCTTAAGGAGATAAAATGAAATTA as a 5' primer and the mutagenic
primers, HdH60Q (5'-TCCGTGGGCTAAATCTTGTAATTTTGG), HdH64E
(5'-GCCATGTAATCCTTCGGCTAAATCGTG), HdH60Q, H64E
(5'-TCCTTCGGCTAAATCTTGTAATTTTGG), and HdM123L
(5'-AGGATCATGTAACACAAATAA) and pIT4 as a template. The PCR-amplified
DNA fragments were purified from agarose gels and used as primers in
the second step of amplification in combination with the 3' primer
5'-CCTGAATTCTTATTTAATTACACCGCATGCC. The resulting amplified DNAs,
encompassing the whole sequence coding for mature Cu,Zn-SOD, were
restricted with NcoI and EcoRI and ligated into plasmid pHEN-1, thus obtaining plasmids pPHduSODQ60,
pPHduSODE64, pPHduSODQ60E64, and pPHduSODL123. The same approach was
used to construct plasmid pPHpSODH64. In this case the mutagenic primer was HpH64 (5'-GCCATGTAAACCGTGAGCTAAACCTTG) and the external primers were Hfor (5'-AACCATGGCCCATGACCATATGGCAAAAC) and Hrev
(5'-CTGAATTCTTATTTAATCACGCCA- CATGC).
Protein Expression and Purification--
Overexpression of
wild type and mutants Cu,Zn-SODs was carried out in E. coli
71/18 cells grown at 37 °C in LB medium containing 100 µg/ml
ampicillin. When cells reached an A600 value of
0.5, Cu,Zn-SOD expression was induced by the addition of 0.1 mM isopropyl- -D-thiogalactopyranoside, 0.25 mM CuSO4, and 10 µM
ZnSO4. Cells were harvested by centrifugation 16 h
after induction. Wild type H. ducreyi Cu,Zn-SOD was purified from periplasmic extracts by immobilized metal affinity chromatography on a nickel-nitrilotriacetic acid (NTA) resin (Qiagen), as described (35). The affinity purified enzyme was further subjected to gel
filtration chromatography on a High Load 16/60 Superdex 75 gel
filtration FPLC (Amersham Pharmacia Biotech). Samples of H. ducreyi Cu,Zn-SOD were subjected to different ion exchange
chromatography tests on Mono Q HR 5/5 or Mono S HR FPLC columns
(Amersham Pharmacia Biotech) with different buffers and pH conditions.
Partial separation of the heme-containing Cu,Zn-SOD from the
heme-devoid enzyme was obtained using the cationic exchange column Mono
S, equilibrated with 20 mM potassium phosphate, pH 6.5, eluting the enzyme with a 0-0.1 M NaCl gradient.
Pure heme-devoid enzyme was obtained by E. coli H500 cells
grown for 24 h in LB medium supplemented with 0.2% glucose, 0.05 mM isopropyl- -D-thiogalactopyranoside, 0.125 mM CuSO4, and 5 µM
ZnSO4. It should be noted that H500 cells grow very poorly, and after 24 h of growth at 37 °C the
A600 of cultures never exceeded 0.5.
H. parainfluenzae and the N-terminal deleted H. ducreyi Cu,Zn-SODs were purified as described (35).
Polyacrylamide Gel Electrophoresis and Heme
Staining--
Polyacrylamide gel electrophoresis under denaturing
conditions (SDS-PAGE) was performed according to Laemmli (42) using a
12.5% resolving gel and a 4.5% stacking gel. Samples were heated at
100 °C for 5 min in a buffer containing 0.1% SDS and 10%
-mercaptoethanol. Gels were stained with Coomassie Brilliant Blue.
In order to detect covalent heme binding by Cu,Zn-SOD, SDS-PAGE gels
were stained for heme-dependent peroxidase activity using
3,3',5,5'-tetramethylbenzidine as an oxidizable substrate, according to
established procedures (43). Before electrophoresis samples were heated
for 5 min at 100 °C in a sample buffer containing 0.1% SDS but
devoid of -mercaptoethanol. Electrophoresis was carried out using
the buffer system described by Laemmli (42), with the addition of 2 mM EDTA. Gels were immersed in a 30:70 methanol, 0.25 M sodium acetate, pH 5.0 solution, containing 1.25 mM 3,3',5,5'-tetramethylbenzidine and kept in constant
shaking at room temperature. After 30 min H2O2
was added to 26 mM. After shaking for a further 15 min, the
same quantity of H2O2 was again added. Gels
were photographed immediately.
Proteins and Heme Analyses--
Protein concentration was
determined by the Lowry method, using bovine serum albumin as a
standard (44). Cu,Zn-SOD molar concentrations were determined assuming
a molecular mass of 38,172 and 32,972 Da for dimeric wild type
and N-terminal deleted H. ducreyi enzyme,
respectively. Superoxide dismutase activity was assayed by the
pyrogallol method (45).
Pyridine hemochromes of Cu,Zn-SOD samples were obtained by diluting the
enzyme with alkaline pyridine and then adding solid sodium dithionite
to the protein solution. Absorption spectra were recorded in a
PerkinElmer Life Sciences Lambda 2 spectrophotometer thermostated at
25 °C, using 1-cm path length cuvettes. Heme content in purified
Cu,Zn-SOD solutions was determined from the absorbance of the -peak
(at 551-556 nm) of the pyridine hemochrome (46), using the value
of 34500 M 1
cm 1 for samples obtained from
hemin-supplemented LB (which contain only limited amounts of covalently
bound heme) or the value of 29100 M 1 cm 1
for samples obtained from standard LB medium. It should be noted, however, that such extinction coefficients provide only an approximate value of heme concentration in Cu,Zn-SOD, due to the variable amount of
covalently bound heme in each protein sample.
Acid-acetone heme extraction was carried out as described by Di Iorio
(47), by dropping small amounts of Cu,Zn-SOD into a large volume excess
of cold ( 20 °C) acid/acetone, prepared by adding 2 ml of 12 N HCl to 1 liter of acetone. After 10 min of centrifugation
at 17,000 × g, the supernatant was discarded, and the
same operation was repeated. Once clear of all traces of acetone, the
final precipitate was dissolved in 100 mM phosphate buffer,
pH 7.0, and the heme content was reanalyzed.
In Vitro Heme Binding Assay--
0.5 mg of heme-deficient
wild type (from H500 E. coli cells) or His-64 Glu
mutant H. ducreyi Cu,Zn-SOD ( 0.013 µmol of enzyme) was
dissolved in 400 µl of 10 mM phosphate buffer, pH 8.0, placed in dialysis bags, and dialyzed against 1 liter of the same
buffer containing 8.48 mg of hemin (13 µmol) with constant stirring. After 15 h of dialysis at room temperature, the samples were
extensively dialyzed against 10 mM phosphate buffer, pH 8.0 (with several changes of the buffer), to remove unbound hemin. The heme
content of each sample was assessed by recording the enzyme absorption spectra in the visible region, whereas the presence of covalently bound
heme was evaluated by acid/acetone extraction and by the staining of
SDS-PAGE gels for heme-dependent peroxidase activity.
Spectroscopy--
Resonance Raman (RR) and electronic absorption
spectra were carried out in 10 mM sodium phosphate buffer
at pH 7.0. The protein samples (N-del 1 and N-del 2) used for spectral
analysis were obtained from cells grown in hemin-enriched LB or in
standard LB, respectively; N-del 1 contained less than 10% covalently
bound heme, whereas N-del 2 contained about 90% covalent heme. The
ferrous forms were prepared by adding a minimum volume of fresh sodium dithionite solution to a deoxygenated buffered solution. Protein concentration was about 0.04-0.15 mM for RR spectroscopy
and about 0.05-0.1 mM for the UV-visible absorption
measurements. The absorption spectra were recorded with a Cary 5 spectrophotometer. The RR spectra were obtained with excitation from
the 406.7-nm line of a Kr+ laser (Coherent Radiation) and
the 514.5-nm line of an Ar+ laser (Coherent Radiation,
Innova/5). The back-scattered light from a slowly rotating NMR tube was
collected and focused into a computer-controlled double monochromator
(Jobin-Yvon HG2S) equipped with a cooled photomultiplier (RCA C31034 A)
and photon-counting electronics. Polarized spectra were obtained by
inserting a Polaroid analyzer between the sample and the entrance slit
of the spectrometer. The depolarization ratios of the bands at 314 and
460 cm 1 of CCl4 were measured to
check the reliability of the polarization measurements using a rotating
NMR tube with a back-scattered geometry. The values obtained, 0.73 and
0.0, compare favorably with the theoretical values, 0.75 and 0.0, respectively. To minimize the heating effects induced on the protein by
the laser beam, RR spectra were collected using a rotating NMR tube
cooled by a gentle flow of N2 gas passed through liquid
N2.
RR spectra were calibrated with indene as standard. The frequencies
were accurate to ±1 cm 1 for the intense
isolated bands and to about ±2 cm 1 for
overlapped bands or shoulders.
Computer-assisted Molecular Modeling--
A molecular model of
H. ducreyi Cu,Zn-SOD was generated using the Swiss
PDB-Viewer (48) starting from the x-ray structure of the highly
homologous Cu,Zn-SOD from A. pleuropneumoniae (see Ref. 26,
Protein Data Bank code 2aps.pdb). Eighteen residues (out of the 155 present in each monomer) were mutated in order to account for all the
differences between the two enzymes.
 |
RESULTS |
Heme Accumulation in the Periplasm of E. coli Cells Expressing H. ducreyi Cu,Zn-SOD--
The periplasmic extracts from E. coli 71/18 cells expressing H. ducreyi Cu,Zn-SOD were
of a reddish color, unlike extracts from control cells. The electronic
absorption spectrum of a periplasmic extract containing this enzyme in
comparison with periplasmic extracts from control cells is shown in
Fig. 1. It shows a pattern typical of
hemoproteins with a main band in the Soret region around 410 nm and
weaker bands close to 530 and 555 nm, indicative of the presence of
relatively large amounts of heme. Initial expression experiments were
carried out with E. coli cells bearing plasmid pIT4. As this
plasmid contains a rather large H. ducreyi chromosomal insert containing genes other than sodC, we performed other
expression experiments using the plasmid pPHduSOD (35). Periplasmic
extracts from cells bearing plasmid pPHduSOD or pIT4 contained
comparable amounts of heme (data not shown). On the contrary, the
periplasmic extracts from cells bearing the control plasmids pEMBL18 or
overexpressing the Cu,Zn-SODs from E. coli,
Photobacterium leiognathi, Haemophilus influenzae,
Haemophilus parainfluenzae, Xenopus laevis B, and Homo sapiens (some of which are reported in Fig. 1)
contained only barely detectable amounts of heme, thus indicating that
heme accumulation in the periplasmic space is specifically related to
the expression of H. ducreyi Cu,Zn-SOD. This phenomenon is independent of the E. coli strain used to express the
H. ducreyi enzyme, as nearly identical spectra were recorded
in extracts from the E. coli strains 71/18, GC4468, and
MC1061 (data not shown).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
Visible absorption spectra of periplasmic
extracts from E. coli 71/18. Extracts were
prepared from 3 × 1010 cells bearing plasmids pIT4,
pJSK326, pEMBL18, pPEcSOD81A, and pPHpSOD. The only two extracts
showing the presence of large amounts of heme were those obtained from
cells bearing pIT4 (spectrum 1) and pJSK326 (spectrum
2). The absorption spectra of extracts from cells expressing
E. coli or H. parainfluenzae Cu,Zn-SODs were
superimposable to those of control cells (bearing pEMBL18) expressing
no Cu,Zn-SOD. Similarly, the extracts from cells expressing other
prokaryotic (H. influenzae, P. leiognathi, and
S. typhimurium) or eukaryotic (X. laevis B and
H. sapiens) Cu,Zn-SODs showed no evidence of heme
accumulation and were not included.
|
|
The histidine-rich N-terminal region of H. ducreyi Cu,Zn-SOD
(25) is not involved in the accumulation of heme, as the periplasmic fraction from cells expressing a mutant devoid of the first 22 amino
acid residues (henceforth referred to as N-terminal deleted Cu,Zn-SOD)
showed an absorption spectrum identical to that of the wild type enzyme
(Fig. 1).
Periplasmic Heme Is Specifically Associated with
Cu,Zn-SOD--
Fig. 2 shows the
absorption spectra of a sample of H. ducreyi Cu,Zn-SOD
purified by affinity chromatography on a Ni-NTA column (spectrum
3) (35), the periplasmic extract (spectrum 1), and the
flow-through eluate (spectrum 2). Nearly all the heme
present in the periplasmic fraction is associated with the purified
enzyme, which, on the basis of SDS-PAGE analysis, appears to be more
than 95% pure (inset, Fig. 2). These findings suggested
that heme could be bound to Cu,Zn-SOD. However, purified enzyme samples
showed very high Cu,Zn-SOD/heme molar ratios (between 80:1 and 5:1,
depending on the enzyme preparations), indicating that there was
significantly less than one heme molecule/Cu,Zn-SOD dimer. So, given
the very high extinction coefficient of the heme cofactor, SDS-PAGE
analysis was not sufficient to exclude the presence of low amounts of
contaminating hemoproteins. The affinity-purified enzyme was therefore
further subjected to gel filtration chromatography. Fig.
3 shows the elution profile of the
enzyme. It shows two main peaks at 38 and 76 kDa and another, less
resolved, peak at higher molecular weight (~110 kDa). All these peaks
were characterized by SOD activity and by the same electronic spectra,
typical of hemoproteins. SDS-PAGE analysis of the different fractions
(Fig. 3, inset) revealed the presence of a main band of 19 kDa and a minor band of 38 kDa. Sequencing of the N-terminal region of
the two bands revealed that they both corresponded to H. ducreyi Cu,Zn-SOD and did not reveal the presence of any
significant amounts of contaminating proteins. Therefore, the 76-kDa
protein is probably a tetrameric form of Cu,Zn-SOD, and the peak of
higher molecular weight is a higher order aggregate of the same
protein.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 2.
Affinity purification of H. ducreyi Cu,Zn-SOD. Electronic absorption spectra in the
visible region of periplasmic extract from E. coli 71/18
expressing H. ducreyi Cu,Zn-SOD (lane 1),
flow-through eluate of the same periplasmic extract loaded onto a
Ni-NTA column (lane 2), and affinity-purified protein
(lane 3) are shown. The inset shows an SDS-PAGE
analysis of the same samples. MW, molecular weight
markers.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
Elution profile of affinity-purified H. ducreyi Cu,Zn-SOD. The protein purified by Ni-NTA
chromatography was injected on to an HiLoadTM 16/60
SuperdexTM 75 gel filtration FPLC column calibrated with
the following molecular weight markers (indicated by black
squares): bovine serum albumin (67,000 Da), ovalbumin (43,000 Da),
chymotrypsinogen A (25,000 Da), and ribonuclease A (13,700 Da).
Proteins present in all the major peaks (numbered from 1 to
3) were analyzed by SDS-PAGE on a 15% gel
(inset).
|
|
Attempts to obtain separation of a putative heme-containing contaminant
protein from Cu,Zn-SOD by ion exchange chromatography (both on anionic
and cationic resins) were unsuccessful, although we obtained a partial
separation of a fraction of Cu,Zn-SOD without heme from the
heme-containing enzyme. In no case could we detect other contaminant
hemoproteins in our Cu,Zn-SOD preparations. However, our attempts to
obtain purified wild type H. ducreyi Cu,Zn-SOD without heme
were severely hampered by progressive degradation of the N-terminal
domain, due to its high protease sensitivity (35), during the different
chromatographic steps.
Since the enzyme lacking the 22-residue N-terminal fragment was more
stable, the heme-containing N-terminal deleted enzyme was purified and
analyzed further. Purification of the N-terminal deleted enzyme was
carried out as described under "Experimental Procedures." Heme
co-eluted with Cu,Zn-SOD in all the chromatographic steps (ion exchange
chromatography on anionic and cationic resins and gel filtration).
Chromatography on a Mono S column at slightly acidic pH allowed the
separation of heme-free Cu,Zn-SOD from the heme-containing enzyme.
Heme-containing Cu,Zn-SOD samples purified by this procedure showed a
Cu,Zn-SOD/heme molar ratio ranging from 1:0.7 to 1:0.95. These values
suggest that one Cu,Zn-SOD dimer binds one heme molecule. SDS analysis
and N-terminal sequencing of the purified heme-containing sample did
not reveal the presence of contaminating proteins.
When cells were grown in standard LB medium, H. ducreyi
Cu,Zn-SOD-associated heme was endogenously produced by E. coli. In fact, we observed that when E. coli 71/18
cells expressing the enzyme were grown in M9 minimal medium, the
purified enzyme contained heme (data not shown). However, when the
enzyme was purified from E. coli 71/18 cells grown in
hemin-enriched media, the Cu,Zn-SOD/heme molar ratio was raised to
values between 5:1 and 2:1. Again, no heme-containing contaminating
proteins could be detected. Therefore, we conclude that the Cu,Zn-SOD
of H. ducreyi is able to bind heme in a highly specific way.
Further evidence for heme binding by H. ducreyi Cu,Zn-SOD
was obtained by studies carried out with the E. coli strain
H500, where hemA, encoding glutamyl-tRNA reductase, has been
deleted and which is, therefore, unable to supply heme (32). H. ducreyi Cu,Zn-SOD purified from E. coli H500 cells did
not contain significant amounts of heme. However, the addition of hemin
to cultures of E. coli hemA cells resulted in efficient heme
uptake by H. ducreyi Cu,Zn-SOD. This also occurred when
hemin was added after the addition of chloramphenicol to block protein synthesis.
Studies on the Heme Nature and the Bond Type in H. ducreyi
Cu,Zn-SOD--
The pyridine hemochrome spectra give a clear indication
of the nature and number of the electron-attracting groups on the heme
chromophore. In the present case, the hemochrome of the enzyme purified
from cells grown in hemin (heme b)-enriched media showed maxima close to 555, 525, and 417 nm (small variability was observed in
different samples), which are almost superimposable on those expected
for free heme. On the other hand the pyridine hemochrome spectrum of
the H. ducreyi enzyme isolated from cells grown in LB medium
showed peaks at about 551, 522 and 414 nm. These values, which are
blue-shifted with respect to those of heme b, are close to
those typical of several proteins with covalently bound heme, containing a c-type heme with one or both vinyl groups
involved in thioether linkages (46).
To investigate the interaction between heme and Cu,Zn-SOD, the enzyme
(both the wild type and the N-terminal deleted form) purified from
standard LB (without hemin supplementation) was subjected to acidic
acetone extraction. Most of the heme (between 70 and 95%, depending on
the preparation) precipitated with the protein, suggesting that the
interaction between heme and Cu,Zn-SOD is very tight. In a different
preparative protocol, purification of the enzyme was carried out by
metal affinity chromatography after overnight incubation of the
periplasmic extract with 6 M guanidine HCl (a treatment
that completely inactivates H. ducreyi Cu,Zn-SOD). The
guanidine-denatured Cu,Zn-SOD showed an affinity for Ni-NTA similar to
that of the native enzyme and eluted with buffers containing 80 mM imidazole. In this case too, heme co-eluted with the
enzyme, and no contaminants could be detected by SDS-PAGE analysis of
the purified protein. Moreover, the association between Cu,Zn-SOD and
heme was not affected by boiling the enzyme in the presence of 2% SDS
prior to loading on Ni-NTA columns or acidic acetone extraction. All
these experiments indicate that there is a tight association between
heme and Cu,Zn-SOD and suggest that heme is covalently bound to the
enzyme. This hypothesis was further supported by staining of denaturing
gels for heme-dependent peroxidase activity, a technique
commonly used to discriminate c-type cytochromes from the
other hemoproteins that lose heme after denaturation (43). As is shown
in Fig. 4, the purified enzyme occurs in
two distinct bands, both of which possess peroxidase activity.
Therefore, we conclude that H. ducreyi Cu,Zn-SOD binds heme
and that at least a fraction of this cofactor is covalently bound to
the enzyme.

View larger version (77K):
[in this window]
[in a new window]
|
Fig. 4.
Heme binding to Cu,Zn-SOD. A,
staining for heme-dependent peroxidase activity of purified
Cu,Zn-SODs. Lane 1, cytochrome c; lane
2, affinity-purified H. ducreyi Cu,Zn-SOD isolated from
E. coli 71/18; lane 3, N-terminal deleted
Cu,Zn-SOD purified from E. coli 71/18 cells; lane
4, affinity-purified H. ducreyi Cu,Zn-SOD isolated from
E. coli H500 cells; lane 5, affinity-purified
H. ducreyi Cu,Zn-SOD isolated from E. coli H500
cells incubated with hemin; lane 6, affinity-purified
H. ducreyi Cu,Zn-SOD isolated from E. coli
MC1061; and lane 7, affinity-purified H. ducreyi
Cu,Zn-SOD isolated from E. coli EC06 cells. B,
Coomassie Blue staining of purified H. ducreyi Cu,Zn-SODs.
Lane 1, molecular weight markers; lanes 2-7,
same samples as A.
|
|
Covalent attachment of heme to the polypeptide chain is typically
observed for cytochromes containing heme c. However,
H. ducreyi Cu,Zn-SOD produced in an E. coli
strain that, lacking the whole ccm operon, is unable to
synthesize mature c-type cytochromes (31, 49) still
contained covalently bound heme (Fig. 4, lane 7), suggesting
that the enzyme does not bind heme c.
Most (60-90%) of the heme associated with Cu,Zn-SOD purified from
hemin-enriched medium could be separated from the polypeptide by acidic
acetone extraction, and peroxidase activity staining showed an abundant
band corresponding to free heme. The enzyme isolated from hemA E. coli H500 cells grown in standard LB medium did not possess
peroxidase activity (Fig. 4, lane 4), since they do not
synthesize the heme cofactor. However, when extracts from hemA cells grown in LB supplemented with hemin were analyzed
for peroxidase activity on SDS-PAGE, Cu,Zn-SOD showed high
heme-dependent peroxidase activity (Fig. 4, lane
5), although a large fraction of the heme molecules bound to
Cu,Zn-SOD detached from the enzyme. This observation suggests that
H. ducreyi Cu,Zn-SOD binds heme b and that this
cofactor is subsequently covalently attached to the enzyme. This
hypothesis was also supported by results obtained by an in
vitro hemin binding assay. In fact, we have observed that after a
15-h dialysis against a buffer containing hemin, the wild type enzyme
isolated from H500 E. coli cells exhibits an electronic
absorption spectrum (not shown) identical to that typical of the enzyme
isolated from cells grown in hemin-enriched media. Interestingly, both
acidic acetone extractions and staining of SDS-PAGE gels for
heme-dependent peroxidase activity demonstrated that a
fraction (close to the 10%) of the heme bound to the enzyme was
covalently bound to the polypeptide.
Fig. 5 shows the electronic absorption
spectra of N-terminal deleted H. ducreyi Cu,Zn-SOD samples
isolated from E. coli 71/18 cells grown in hemin-enriched
media (N-del 1) (Fig. 5A) and from E. coli cells
grown in standard LB medium (containing more than 80% covalent heme)
(N-del 2) (Fig. 5B) in both the oxidized (bottom) and the reduced (top) forms. The spectra of N-del 1 are 1-3
nm red-shifted with respect to those of N-del 2 and are very similar to
those of cytochrome b5 (50). The spectra are
characteristic of 6-coordinated low spin (6-c LS) hemes. Moreover, the
shape and the wavelength maxima of the - and -bands of the ferric forms indicate the presence of histidine residues as fifth and sixth
ligands of the heme iron. In fact, it has been suggested that maxima at
about 530 and 560 nm together with their relative intensity are
characteristic of a bis-imidazole complex (51).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
Electronic absorption spectra of N-deleted
Cu,Zn-SOD. Samples isolated from E. coli 71/18 cells
grown in hemin-enriched media (N-del 1) (A) and from
E. coli cells grown in standard LB medium (N-del 2)
(B) are shown in their oxidized (bottom) and
reduced (top) forms. The visible region of the reduced and
oxidized spectra have been expanded 5- and 8-fold, respectively.
|
|
Fig. 6 compares the RR spectra in the
high frequency region for the ferric forms of N-del 1 (Fig.
6A) and N-del 2 (Fig. 6B), taken with Soret
(406.7 nm) and visible (514.5 nm) excitations and in polarized light.
The totally symmetric modes, together with the (C=C) stretching mode
of the vinyl substituents (polarized), are enhanced via the A-term in
the Soret excitation and the non-totally symmetric modes are mainly
enhanced, via vibronic mixing, in the visible excitation (52). In
agreement with the electronic absorption spectra, both proteins have
core size marker bands typical of 6-c LS hemes ( 4, 1374 cm 1; 3, 1504 cm 1; 11, 1564-1565
cm 1; 2, 1578-1583
cm 1; 19, 1584-1586
cm 1; and 10, 1638-1639
cm 1). However, they markedly differ in the
region 1600-1630 cm 1. N-del 1 exhibits two
polarized bands, present only in the Soret excitation, at 1619 and 1628 cm 1, assigned to the (C=C) stretching
modes of the vinyl groups. N-del 2 shows only one polarized band at
1619 cm 1. This might be due to only one vinyl
stretch or the two vinyl substituents that give rise to a coincident
band at 1619 cm 1, as in the case of myoglobin
(53). In general, a down-shift of the vinyl band frequency from
1628-1619 cm 1 indicates a strong conjugation
of the vinyl double bond with the heme. As a consequence, a red-shift
of the electronic absorption spectra is expected. On the contrary,
compared with N-del 1, N-del 2 is characterized by an overall
blue-shift of the electronic absorption spectra of both the ferric and
ferrous forms. Moreover, the 2 mode of N-del 2 up-shifts
by 5 cm 1 with respect to the frequency
observed for N-del 1. It is known that the 2 mode is
coupled to the vinyl (C=C) mode in protohemes, and saturation of the
vinyl groups raises the 2 frequencies by about 10 cm 1 (52). The RR spectra of the ferrous forms
show a similar behavior. N-del 1 is characterized by two (C=C)
stretches, and the 2 mode at 1583 cm 1, N-del 2 displays one (C=C) stretch
and the 2 mode at 1586 cm 1
(data not shown). Therefore, the combined analysis of the electronic and RR spectra indicates that the two proteins have different heme
types as follows: a b-type (with two vinyl groups) in N-del 1, and a heme with only one vinyl group in N-del 2.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 6.
Resonance Raman spectra of N-deleted
Cu,Zn-SOD. Resonance Raman spectra in the high frequency region of
ferric N-del 1 (A) and N-del 2 (B) taken with
406.7 and 514.5 nm and in polarized light. Experimental conditions, 5 cm 1 resolution. A, 406.7 nm, 15 milliwatt laser power at the sample; np,
non-polarized, 38 s/0.5 cm 1 collection
interval; par, parallel polarization, 30 s/0.5
cm 1 collection interval; per,
perpendicular polarization, 40 s/0.5 cm 1
collection interval; 514.5 nm, 75-milliwatt laser power at
the sample, 15 s/0.5 cm 1 collection interval.
B, 406.7 nm, 15-milliwatt laser power at the
sample; non-polarized, 23 s/0.5
cm 1 collection interval; parallel
polarization, 35 s/0.5 cm 1 collection
interval; perpendicular polarization, 45 s/0.5
cm 1 collection interval; 514.5 nm,
75-milliwatt laser power at the sample, 10 s/0.5
cm 1 collection interval.
|
|
Histidine 64 Is Required for Heme Binding--
The spectroscopic
data suggest as putative ligands for the heme iron two histidine
residues. H. ducreyi Cu,Zn-SOD is characterized by an
unusually high content of histidine residues (35). In order to identify
the possible histidine ligands, we compared the amino acids sequence of
the H. ducreyi enzyme with those of H. parainfluenzae and Actinobacillus pleuropneumoniae, two
enzymes that are not able to bind heme (Fig.
7). Apart from the N-terminal histidines,
which are not required for heme binding, H. ducreyi Cu,Zn-SOD has two histidine residues (His-60 and His-64) that are not
present in the H. parainfluenzae enzyme. These two residues were, therefore, considered as potential candidates for site-directed mutagenesis studies. It should be noted that the alignment of all known
bacterial Cu,Zn-SODs indicates that a histidine in position 60 is
present in the enzyme from A. pleuropneumoniae, whereas histidine 64 is unique to H. ducreyi Cu,Zn-SOD (26, 35,
54).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 7.
Alignment of amino acid sequences of
H. ducreyi, A. pleuropneumoniae, and
H. parainfluenzae Cu,Zn-SODs. The amino acid
numbering of H. ducreyi Cu,Zn-SOD, shown on the top
line, is used as reference. All histidine residues are highlighted
in red, and black arrows mark copper and zinc
ligands, indicated by C and Z, respectively.
Boxes and red arrows mark the amino acids that
have been mutated in this work.
|
|
Two single His mutants of H. ducreyi Cu,Zn-SOD, in which
His-60 and His-64 were replaced by glutamine or aspartic acid,
respectively, and the double mutant, were produced and expressed in
E. coli 71/18 cells grown in standard LB medium. The
electronic spectra of the periplasmic extracts from cells expressing
the His-60 Gln mutant enzyme were identical to those of
cells expressing the wild type enzyme, thus indicating that His-60 is
not required for heme binding. In contrast, extracts from cells
expressing the mutants His-64 Glu and His-60 Gln, His-64 Glu did not contain appreciable amounts of heme. Wild type and mutant
enzymes were purified by immobilized metal affinity chromatography on Ni-NTA columns, and their ability to bind heme was assessed by heme-staining in SDS gels. As shown in Fig.
8, mutants lacking His-64 did not show
heme-dependent peroxidase activity, indicating that this
residue is required for heme binding. Similar results were obtained
when the mutant enzymes were purified from cells grown in LB
supplemented with hemin. Moreover, unlike the wild type enzyme, upon
dialysis against a buffer containing a 1000-fold molar excess of hemin
the His-64 Glu mutant enzyme contained only a barely detectable
amount of heme.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 8.
His-64 is required for heme
binding. A, staining for heme-dependent
peroxidase activity of purified wild type and mutant Cu,Zn-SODs.
Lane 1, cytochrome c; lane 2, wild
type H. ducreyi Cu,Zn-SOD; lane 3, His-60 Gln
mutant; lane 4, His-60 Gln,His-64 Glu double mutant;
lane 5, His-64 Glu mutant; lane 6, wild type
H. parainfluenzae Cu,Zn-SOD; and lane 7, Glu-64
His mutant H. parainfluenzae Cu,Zn-SOD. B,
Coomassie Blue staining of the same samples loaded in gel A. Lane
1 contains molecular weight markers in place of cytochrome
c.
|
|
Recently, the x-ray structure of A. pleuropneumoniae
Cu,Zn-SOD has been determined at 2.1-Å resolution (26). This enzyme shows a very high degree of homology with the H. ducreyi
enzyme (88.4% identity excluding the N-terminal extension). Moreover, 18 of the 19 residues involved in dimer formation in A. pleuropneumoniae Cu,Zn-SOD (26, 27, 54) are conserved in the
H. ducreyi enzyme, suggesting a nearly identical subunit
assembly in the two enzymes (the only mutation being the substitution
of an Asn residue with Ile at position 130 of H. ducreyi
Cu,Zn-SOD). In view of these considerations, we used the A. pleuropneumoniae enzyme as a template to model the
three-dimensional structure of H. ducreyi Cu,Zn-SOD employing the Swiss PDB-Viewer facility. Fig.
9 shows the hypothetical dimeric
structure of H. ducreyi Cu,Zn-SOD and highlights the
position of His-60 (green), His-64 (red), and the
disulfide bond (blue). His-60 is located on the molecule
surface and is solvent-exposed. In contrast, His-64 is located just
below the surface of association between the two subunits and lies on
the 2-fold symmetry axis that crosses the dimer interface, in a region
that appears to be only partially accessible to the solvent. The side
chains of His-64 in the two subunits point toward one another at a
distance that, in the model generated by the Swiss PDB-Viewer, is close to 3 Å. Although such a distance is too short to accommodate a heme
cofactor having His-64 as axial ligands, it must be considered that
this distance comes from a model in which the orientation of the main
chain was left identical to that of the template. Only small
conformational changes are required to increase the distance between
the two axial ligands to about 4 Å, in order to easily accommodate the
heme group. The only two cysteine residues present in each subunit and
which form a disulfide bond in A. pleuropneumoniae
Cu,Zn-SOD, as well as in all the other characterized Cu,Zn-SOD, are
quite far from His-64. Therefore, it is very unlikely that these
cysteine residues are involved in a covalent linkage through two
thioether bonds if the heme is coordinated to His-64.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 9.
Molecular model of H. ducreyi
Cu,Zn-SOD. His-64 is shown in red, His-60 in
green, the disulfide bond in blue, and Met-123 in
yellow. The spheres present in each enzyme
subunit indicate the position occupied by the zinc (pale
gray) and copper ion (dark gray), respectively. This
enzyme view emphasizes the highly symmetrical structure of bacterial
Cu,Zn-SOD. It should be noted, however, that while the two His-64
residues are at a distance of about 3 Å, the two Met-123 residues are
more than 10 Å from each other.
|
|
We have also inspected the model in search of other residues possibly
involved in heme binding. The side chains closest to His-64 in each
enzyme subunit are those from Phe-121 and Val-122, which are both
involved in dimer formation, and from His-124 and Met-123. Although
His-126 is present also in the Cu,Zn-SOD from all the other
Haemophilus species, Met-123 is not present in the Cu,Zn-SODs from A. pleuropneumoniae and H. parainfluenzae nor in any other bacterial Cu,Zn-SOD (in Fig. 9
Met-123 is shown in yellow). To evaluate if mutation of this
residue might affect heme binding, we have engineered a mutant enzyme
carrying the Met-123 Leu substitution. This mutant is still able to
bind heme and is still a 6-c LS heme, but the affinity for the cofactor is more than 10-fold decreased with respect to the wild type enzyme (data not shown).
In order to evaluate whether a His residue at the dimer interface is
sufficient to allow heme binding by other Cu,Zn-SODs, the enzyme from
H. parainfluenzae was engineered to introduce a histidine in
position 64 (Gln-64 His mutant). Wild type and mutant enzymes
expressed in E. coli 71/18 cells were purified by metal
affinity chromatography and analyzed for their heme content by
peroxidase staining. Both the electronic spectra (data not shown) and
heme staining of denaturing polyacrylamide gels (Fig. 8) failed to
identify heme in the purified proteins, even in extracts from cells
grown in media enriched with hemin.
 |
DISCUSSION |
X-ray structures of four different bacterial Cu,Zn-SODs have shown
that prokaryotic and eukaryotic Cu,Zn-SODs share a similar monomer
fold, based on a flattened Greek-key eight-stranded -barrel and a
similar organization of the metal cluster (26, 27, 54-56). Bacterial
Cu,Zn-SODs are, however, characterized by a different architecture of
the active site channel and a distinctive quaternary assembly (54).
Whereas all the eukaryotic enzymes are characterized by a very high
degree of structural conservation (57), among prokaryotic Cu,Zn-SODs
significant structural variations have been observed or may be inferred
from their amino acid sequences. Most of these differences concern the
quaternary structure. Although most prokaryotic Cu,Zn-SODs have been
shown to be dimeric, some are monomeric (36, 54, 56, 58, 60), and the
subunit:subunit recognition modality may change in some dimeric
variants (27, 54). Other peculiar features that may be observed in
specific bacterial Cu,Zn-SOD include the substitution of some of the
metal ligands (25, 54, 59), insertion or deletion in the major loops
connecting the -strands (54), and the presence of metal-binding extensions at the N terminus (35). The finding that the Cu,Zn-SOD from
H. ducreyi is able to bind heme further emphasizes the
structural and functional variability of this class of enzymes. The
spectral features of this protein suggest that histidine ligands could be involved in the heme iron coordination, as also indicated by site-directed mutagenesis experiments showing that the His-64 residue
is required for heme binding. These observations have been rationalized
by inspection of a structural model of the enzyme, which has been
generated starting from the structure of the highly homologous enzyme
from A. pleuropneumoniae. We are aware that molecular
details suggested by modeling could in part differ from those found in
the real enzyme and that heme binding could induce structural
rearrangements that we have not taken into account. However, such a
model provides a clear explanation for the pivotal role of His-64 in
heme binding. This residue has been located at the center of symmetry
at the dimer interface, so that the side chains of the His-64 residues
on the two subunits point toward each other, in such an arrangement as
to be suitable for direct coordination of iron. Recent studies have
suggested a role for the dimeric structure in modulating enzyme
stability and activity both in eukaryotic and prokaryotic Cu,Zn-SODs
(27, 61-63). In this case the dimer interface builds up an additional
cofactor-binding site. However, the observation that a mutant H. parainfluenzae Cu,Zn-SOD containing a histidine residue in the
position corresponding to that of H. ducreyi His-64 is
unable to bind heme indicates that other residues must be involved in
the formation of a heme-binding pocket. In agreement with this
hypothesis we have observed that the affinity for heme of H. ducreyi Cu,Zn-SOD is dramatically decreased upon mutation of
Met-123, a residue close to His-64.
Comparison of the sequences of all known bacterial Cu,Zn-SODs shows
that His-64 is present only in the enzyme from H. ducreyi, and none of the other Cu,Zn-SODs (prokaryotic and eukaryotic) that we
have tested show any affinity for heme. This finding raises the
question of whether Cu,Zn-SOD heme-binding ability is related to one of
the most striking features of H. ducreyi, namely its absolute requirement to obtain heme from the host. In principle, heme
could serve as a cofactor for additional catalytic activities involved
in protecting the organism from reactive nitrogen or oxygen
intermediates other than superoxide, which are produced during the
phagocytic oxidative burst. An alternative possibility could relate to
the potential toxicity of "free" heme for the bacterial cell. How
H. ducreyi obtains sufficient amounts of this essential
cofactor in vivo is not known, but it produces toxins that
can induce hemolysis, and it is possible that at some stage of
infection the bacterium could be exposed to a potentially dangerous heme overload. Under such conditions the binding of heme to Cu,Zn-SOD could protect the bacterial cell from damage due to oxyradicals formed
upon the reaction of heme iron with oxygen. In this perspective, Cu,Zn-SOD may act as a periplasmic protein able to store heme when its
availability exceeds the needs of the cell. However, as heme is bound
stoichiometrically to Cu,Zn-SOD, this hypothesis raises the question of
how this might serve the bacterial cell under conditions (should they
ever occur) of saturating heme concentrations. Alternatively, it is
possible to hypothesize that Cu,Zn-SOD might participate, via the
transient binding of heme, in the mechanisms of heme transport from
membrane-localized receptors to other cellular targets. This hypothesis
is obviously in contrast with the possibility that heme should be
covalently attached to Cu,Zn-SOD when this enzyme is expressed in
H. ducreyi. Further work is required to explain why H. ducreyi Cu,Zn-SOD is able to bind heme and to understand whether
covalent binding of heme to Cu,Zn-SOD reflects a functionally important
property of the enzyme, an artifact of the E. coli
expression system, or some other not yet defined possibility.
An interesting question raised by the present results is the nature of
the heme cofactor bound to the H. ducreyi Cu,Zn-SOD when it
is produced in E. coli. The enzyme is able to bind heme b, as demonstrated by the UV-visible, RR, and pyridine
hemochrome spectra of N-del 1. Although heme b is expected
to be the most important heme source for H. ducreyi, we
observed that a large part of heme bound by the recombinant enzyme
expressed in E. coli is covalently attached to the protein,
as the case of N-del 2 protein. Covalent attachment of heme is
frequently observed in c-type cytochromes, where two
thioether linkages are formed between the vinyl groups of the heme and
two cysteine residues, usually within a CXXC motif (64).
H. ducreyi Cu,Zn-SOD does not contain such a motif, since it
contains only two cysteine residues that are involved in the formation
of a disulfide bond, essential for enzyme stability and activity (38).
The structural model of the enzyme indicates that these two cysteine
residues are very distant from the putative iron ligand His-64. As a
consequence, this residue could coordinate to the heme iron linked to
the apoprotein via thioether bonds only after an extensive loss of
quaternary and, perhaps, tertiary structures. This is not compatible
with our findings that the enzyme containing covalently bound heme exhibits catalytic activity and spectroscopic properties similar to the
enzyme containing mainly non-covalent heme.
Further evidence that heme c does not bind to the enzyme has
come from expression studies in an E. coli strain lacking
the whole ccm operon. A ccm strain is unable to
synthesize mature c-type cytochromes (31, 49), but
recombinant H. ducreyi Cu,Zn-SOD expressed in this strain
does contain high amounts of covalently bound heme. The spectroscopic
data of the N-del 2 sample together with its pyridine ferrohemochrome
suggest that the cofactor is a heme containing one vinyl group. In
particular, the RR spectra clearly show only one (C=C) stretch, and
the bands in the UV-visible spectrum of the ferrous forms are 4-8 nm
red-shifted with respect to ferrous cytochrome c (65), which
does not contain any vinyl groups, and about 2-3 nm blue-shift with
respect to N-del 1 (which contains two vinyl substituents). Therefore,
although the present investigation does not provide information about
the protein residues involved in covalent binding of heme, we suggest
that heme is covalently bound to the protein via the saturation of the
double bonds of one of the two vinyl substituents. However, it is
difficult, at the present stage, to give a conclusive definition of the
nature of the heme. It is very unlikely that H. ducreyi
Cu,Zn-SOD binds heme c, but the growing body of evidence
indicating that covalent attachment of chemically modified heme
b, such as that found in lactoperoxidase (66), eosinophil
peroxidase (67), thyroperoxidase (68), and myeloperoxidase (69), is not
uncommon leads us to suggest that the covalently bound heme cofactor
associated with recombinant H. ducreyi Cu,Zn-SOD could be a
derivative of heme b.
 |
ACKNOWLEDGEMENTS |
We are indebted to Linda Thony Meier for
providing the ccm E. coli mutant strain, to Dr. M. Inokuchi
for providing the hemA strain H500, and to Dr. Concetta Capo for
N-terminal sequencing of H. ducreyi Cu,Zn-SOD.
 |
FOOTNOTES |
*
This work was supported in part by the MURST-CNR program
L.95/95 "Biomolecole per la Salute Umana," the CNR target project on Biotechnology, The Wellcome Trust (to J. S. K. and P. R. L.), and by MURST.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Dip. di Biologia,
Università di Roma "Tor Vergata," Via della Ricerca
Scientifica, 00133 Roma, Italy. Tel.: 39 0672594372; Fax: 39 0672594311; E-mail: andrea.battistoni@uniroma2.it.
Published, JBC Papers in Press, May 21, 2001, DOI 10.1074/jbc.M010488200
 |
ABBREVIATIONS |
The abbreviations used are:
Cu, Zn-SOD,
Cu,Zn-superoxide dismutase;
RR, resonance Raman;
LB, Luria-Bertani
broth;
PCR, polymerase chain reaction;
PAGE, polyacrylamide gel
electrophoresis;
6-c LS, 6-coordinated low spin.
 |
REFERENCES |
| 1.
|
Guerinot, M. L.
(1994)
Annu. Rev. Microbiol.
48,
743-772
|
| 2.
|
Wandersman, C.,
and Stojiljkovic, I.
(2000)
Curr. Opin. Microbiol.
3,
215-220
|
| 3.
|
Wasserheit, J. N.
(1992)
Sex. Transm. Dis.
19,
61-77
|
| 4.
|
Telzak, E. E.,
Chiasson, M. A.,
Bevier, P. J.,
Stoneburner, R. L.,
Castro, K. G.,
and Jaffe, H. W.
(1993)
Ann. Intern. Med.
119,
1181-1186
|
| 5.
|
Lee, B. C.
(1991)
J. Med. Microbiol.
34,
317-22
|
| 6.
|
Totten, P. A.,
and Stamm, W. E.
(1994)
J. Clin. Microbiol.
32,
2019-2023
|
| 7.
|
Elkins, C.
(1995)
Infect. Immun.
63,
1241-1245
|
| 8.
|
Thomas, C. E.,
Olsen, B.,
and Elkins, C.
(1998)
Infect. Immun.
66,
4254-4262
|
| 9.
|
Al-Tawfiq, J. A.,
Fortney, K. R.,
Katz, B. P.,
Hood, A. F.,
Elkins, C.,
and Spinola, S. M.
(2000)
J. Infect. Dis.
181,
1049-1054
|
| 10.
|
Palmer, K. L.,
and Munson, R. S., Jr.
(1995)
Mol. Microbiol.
18,
821-830
|
| 11.
|
Cope, L. D.,
Lumbley, S.,
Latimer, J. L.,
Klesney-Tait, J.,
Stevens, M. K.,
Johnson, L. S.,
Purven, M.,
Munson, R. S., Jr.,
Lagergard, T.,
Radolf, J. D.,
and Hansen, E. J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
4056-4061
|
| 12.
|
Campagnari, A. A.,
Wild, L. M.,
Griffiths, G. E.,
Karalus, R. J.,
Wirth, M. A.,
and Spinola, S. M.
(1991)
Infect. Immun.
59,
2601-2608
|
| 13.
|
Brentjens, R. J.,
Ketterer, M.,
Apicella, M. A.,
and Spinola, S. M.
(1996)
J. Bacteriol.
178,
808-816
|
| 14.
|
Langford, P. R.,
and Kroll, J. S.
(1997)
FEMS Immunol. Med. Microbiol.
17,
235-242
|
| 15.
|
San Mateo, L. R.,
Hobbs, M. M.,
and Kawula, T. H.
(1998)
Mol. Microbiol.
27,
391-404
|
| 16.
|
Kroll, J. S.,
Langford, P. R.,
Wilks, K. E.,
and Keil, A. D.
(1995)
Microbiology
141,
2271-2279
|
| 17.
|
De Groote, M. A.,
Ochsner, U. A.,
Shiloh, M. U.,
Nathan, C.,
McCord, J. M.,
Dinauer, M. C.,
Libby, S. J.,
Vazquez-Torres, A.,
Xu, Y.,
and Fang, F. C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
13997-14001
|
| 18.
|
Battistoni, A.,
Donnarumma, G.,
Greco, R.,
Valenti, P.,
and Rotilio, G.
(1998)
Biochem. Biophys. Res. Commun.
243,
804-807
|
| 19.
|
Tatum, F. M.,
Detilleux, P. G.,
Sacks, J. M.,
and Halling, S. M.
(1992)
Infect. Immun.
60,
2863-2869
|
| 20.
|
Farrant, J. L.,
Sansone, A.,
Canvin, J. R.,
Pallen, M. J.,
Langford, P. R.,
Wallis, T. S.,
Dougan, G.,
and Kroll, J. S.
(1997)
Mol. Microbiol.
25,
785-796
|
| 21.
|
Fang, F. C.,
DeGroote, M. A.,
Foster, J. W.,
Baumler, A. J.,
Ochsner, U.,
Testerman, T.,
Bearson, S.,
Giard, J. C.,
Xu, Y.,
Campbell, G.,
and Laessig, T.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
7502-7507
|
| 22.
|
Figueroa-Bossi, N.,
and Bossi, L.
(1999)
Mol. Microbiol.
33,
167-176
|
| 23.
|
Wilks, K. E.,
Dunn, K. L.,
Farrant, J. L.,
Reddin, K. M.,
Gorringe, A. R.,
Langford, P. R.,
and Kroll, J. S.
(1998)
Infect. Immun.
66,
213-217
|
| 24.
|
San Mateo, L. R.,
Toffer, K., L.,
Orndorff, P. E.,
and Kawula, T. H.
(1999)
Infect. Immun.
67,
5345-5351
|
| 25.
|
Kroll, J. S.,
Langford, P. R.,
and Loynds, B. M.
(1992)
J. Bacteriol.
173,
7449-7457
|
| 26.
|
Forest, K. T.,
Langford, P. R.,
Kroll, J. S.,
and Getzoff, E. D.
(2000)
J. Mol. Biol.
296,
145-153
|
| 27.
|
Pesce, A.,
Battistoni, A.,
Stroppolo, M. E.,
Polizio, F.,
Nardini, M.,
Kroll, J. S.,
Langford, P. R.,
O'Neill, P.,
Sette, M.,
Desideri, A.,
and Bolognesi, M.
(2000)
J. Mol. Biol.
302,
465-478
|
| 28.
|
Messing, J.,
Gronenborn, B.,
Muller-Hill, B.,
and Hans-Hopschneider, P.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
3642-3646
|
| 29.
|
Carlioz, A.,
and Touati, D.
(1986)
EMBO J.
5,
623-630
|
| 30.
|
Meissner, P. S.,
Sisk, P. W.,
and Berman, M. L.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
4171-4175
|
| 31.
|
Thöny-Meyer, L.,
Fischer, F.,
Kunzler, P.,
Ritz, D.,
and Hennecke, H.
(1995)
J. Bacteriol.
177,
4321-4326
|
| 32.
|
Nakayashiki, K.,
Nishimura, K.,
Tanaka, R.,
and Inokuchi, H.
(1995)
Mol. Gen. Genet.
249,
139-146
|
| 33.
|
Dente, L.,
Cesareni, G.,
and Cortese, R.
(1983)
Nucleic Acids Res.
11,
1645-1655
|
| 34.
|
Hoogenboom, H.,
Griffiths, A. D.,
Johnson, K. S.,
Chiswell, D. J.,
Hudson, P.,
and Winter, G.
(1991)
Nucleic Acids Res.
19,
4133-4137
|
| 35.
|
Battistoni, A.,
Pacello, F.,
Mazzetti, A. P.,
Capo, C.,
Kroll, S. J.,
Langford, P. R.,
Donnarumma, G.,
Valenti, P.,
and Rotilio, G.
(2001)
J. Biol. Chem.
275,
30315-30325
|
| 36.
|
Battistoni, A.,
Folcarelli, S.,
Gabbianelli, R.,
Capo, C.,
and Rotilio, G.
(1996)
Biochem. J.
320,
713-716
|
| 37.
|
Foti, D.,
LoCurto, B.,
Cuzzocrea, G.,
Stroppolo, M. E.,
Polizio, F.,
Venanzi, M.,
and Desideri, A.
(1997)
Biochemistry
36,
7109-7113
|
| 38.
|
Battistoni, A.,
Mazzetti, A. P.,
and Rotilio, G.
(1999)
FEBS Lett.
413,
313-316
|
| 39.
|
Carrì, M. T.,
Battistoni, A.,
Polizio, F.,
Desideri, A.,
and Rotilio, G.
(1994)
FEBS Lett.
356,
314-316
|
| 40.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed., Vol. 3
, p. A3, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 41.
|
Folcarelli, S.,
Battistoni, A.,
Falconi, M.,
O'Neill, P.,
Rotilio, G.,
and Desideri, A.
(1998)
Biochem. Biophys. Res. Commun.
244,
908-911
|
| 42.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 43.
|
Thomas, P. E.,
Ryan, D.,
and Levin, W.
(1976)
Anal. Biochem.
75,
168-176
|
| 44.
|
Lowry, H. O.,
Rosebrough, N. J.,
Farr, L. A.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275
|
| 45.
|
Marklund, S.,
and Marklund, G.
(1974)
Eur. J. Biochem.
47,
469-474
|
| 46.
|
Smith, L.
(1978)
Methods Enzymol.
53,
202-212
|
| 47.
|
Di Iorio, E. E.
(1981)
Methods Enzymol.
76,
57-72
|
| 48.
|
Guex, N.,
and Peitsch, M. C.
(1997)
Electrophoresis
18,
2714-2723
|
| 49.
|
Thony-Meyer, L.
(1997)
Microbiol. Mol. Biol. Rev.
61,
337-376
|
| 50.
|
Strittmatter, P.,
and Velick, S. F.
(1956)
J. Biol. Chem.
221,
253-264
|
| 51.
|
Smulevich, G.,
Miller, M. A.,
Kraut, J.,
and Spiro, T. G.
(1991)
Biochemistry
30,
9546-9558
|
| 52.
|
Choi, S.,
Spiro, T. G.,
Langry, K. C.,
Smith, K. M.,
Budd, D. L.,
and La Mar, G. N.
(1982)
J. Am. Chem. Soc.
104,
4345-4351
|
| 53.
|
Hu, S.,
Smith, K. M.,
and Spiro, T. G.
(1996)
J. Am. Chem. Soc.
118,
12638-12646
|
| 54.
|
Bordo, D.,
Matak, D.,
Djinovic-Carugo, K.,
Rosano, C.,
Pesce, A.,
Bolognesi, M.,
Stroppolo, M. E.,
Falconi, M.,
Battistoni, A.,
and Desideri, A.
(1999)
J. Mol. Biol.
285,
283-296
|
| 55.
|
Bourne, Y.,
Redford, S. M.,
Steinman, H. M.,
Lepock, J. R.,
Tainer, J. A.,
and Getzoff, E. D.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12774-12779
|
| 56.
|
Pesce, A.,
Capasso, C.,
Battistoni, A.,
Folcarelli, S.,
Rotilio, G.,
Desideri, A.,
and Bolognesi, M.
(1997)
J. Mol. Biol.
274,
408-420
|
| 57.
|
Bordo, D.,
Djinovic-Carugo, K.,
and Bolognesi, M.
(1994)
J. Mol. Biol.
238,
366-368
|
| 58.
|
Battistoni, A.,
and Rotilio, G.
(1995)
FEBS Lett.
374,
199-202
|
| 59.
|
Steinman, H. M.,
and Ely, B.
(1990)
J. Bacteriol.
172,
2901-2910
|
| 60.
|
Battistoni, A.,
Folcarelli, S.,
Cervone, L.,
Polizio, F.,
Desideri, A.,
Giartosio, A.,
and Rotilio, G.
(1998)
J. Biol. Chem.
273,
5655-5661
|
| 61.
|
Banci, L.,
Bertini, I.,
Cramaro, F.,
Del Conte, R.,
Rosato, A.,
and Viezzoli, M. S.
(2000)
Biochemistry
39,
9108-9118
|
| 62.
|
D'Orazio, M.,
Battistoni, A.,
Stroppolo, M. E.,
and Desideri, A.
(2000)
Biochem. Biophys. Res. Commun.
272,
81-83
|
| 63.
|
Stroppolo, M. E.,
Pesce, A.,
Falconi, M.,
O'Neill, P.,
Bolognesi, M.,
and Desideri, A.
(2000)
FEBS Lett.
483,
20-26
|
| 64.
|
Pettigrew, G. W.,
and Moore, G. R.
(1990)
in
Cytochrome c: Evolutionary, Structural and Physicochemical Aspects
(Rich, A., ed)
, Springer-Verlag, Berlin
|
| 65.
|
Spiro, T. G.,
and Li, X.-Y.
(1988)
in
Biological Applications of Raman Spectroscopy
(Spiro, T. G., ed), Vol. 3
, pp. 1-37, Wiley-Interscience, New York
|
| 66.
|
DePillis, G. D.,
Ozaki, S.,
Kuo, J. M.,
Maltby, D. A.,
and Ortiz de Montellano, P. R.
(1997)
J. Biol. Chem.
272,
8857-8860
|
| 67.
|
Oxvig, C.,
Thomsen, A. R.,
Overgaard, M. T.,
Sorensen, E. S.,
Hojrup, P.,
Bjerrum, M. J.,
Gleich, G. J.,
and Sottrup-Jensen, L.
(1999)
J. Biol. Chem.
274,
16953-16958
|
| 68.
|
Fayadat, L.,
Niccoli-Sire, P.,
Lanet, J.,
and Franc, J. L.
(1999)
J. Biol. Chem.
274,
10533-10538
|
| 69.
|
Fiedler, T. J.,
Davey, C. A.,
and Fenna, R. E.
(2000)
J. Biol. Chem.
275,
11964-11971
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. V. Balashova, D. H. Park, J. K. Patel, D. H. Figurski, and S. C. Kachlany
Interaction between Leukotoxin and Cu,Zn Superoxide Dismutase in Aggregatibacter actinomycetemcomitans
Infect. Immun.,
September 1, 2007;
75(9):
4490 - 4497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Krishnakumar, B. Kim, E. A. Mollo, J. A. Imlay, and J. M. Slauch
Structural Properties of Periplasmic SodCI That Correlate with Virulence in Salmonella enterica Serovar Typhimurium
J. Bacteriol.,
June 15, 2007;
189(12):
4343 - 4352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. B. Post, R. Mungur, B. W. Gibson, and R. S. Munson Jr.
Identification of a Novel Sialic Acid Transporter in Haemophilus ducreyi
Infect. Immun.,
October 1, 2005;
73(10):
6727 - 6735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. H. Bong, K. R. Fortney, B. P. Katz, A. F. Hood, L. R. S. Mateo, T. H. Kawula, and S. M. Spinola
A Superoxide Dismutase C Mutant of Haemophilus ducreyi Is Virulent in Human Volunteers
Infect. Immun.,
March 1, 2002;
70(3):
1367 - 1371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Battistoni, F. Pacello, A. P. Mazzetti, C. Capo, J. S. Kroll, P. R. Langford, A. Sansone, G. Donnarumma, P. Valenti, and G. Rotilio
A Histidine-rich Metal Binding Domain at the N Terminus of Cu,Zn-Superoxide Dismutases from Pathogenic Bacteria. A NOVEL STRATEGY FOR METAL CHAPERONING
J. Biol. Chem.,
August 3, 2001;
276(32):
30315 - 30325.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|